Your Source for Venture Capital and Private Equity Financings

Access Vascular Raises $22M Series C Funding

2023-10-31
BILLERICA, MA, Access Vascular has raised a Series C round worth $22 million from a consortium of new and existing investors.
Access Vascular, a company addressing the most common and costly vascular access complications with its advanced biomaterial platform, today announced that it raised a Series C round worth $22 million from a consortium of new and existing investors.

Access Vascular was founded to address the most common and costly complications of intravenous therapy: infection, thrombosis, and phlebitis. Taking a foundationally different approach to thrombus reduction, the company manufactures intravenous catheters from a proprietary hydrophilic material. Engineered to mimic the body's natural chemistry, Access Vascular catheters are designed to evade the foreign body response and the complications that come with it.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors